Medplus Health Services announces ₹130 crore buyback

What happened

Medplus Health Services (MEDPLUS) filed a disclosure with the exchanges on 6 November 2026 at 12:51 PM titled "Outcome of Board Meeting held on November 06, 2026, approving the buyback of equity shares".

How big is it?

At ₹130 crore, the buyback is equal to about 1.8% of the company's market value of ₹7,211 crore.

Company snapshot

Medplus Health Services is a small-cap company in the Consumer Services sector, with a market value of about ₹7,211 crore.

The stock last traded at ₹600.2, against a 52-week range of ₹565.6–₹1,022.2 (41.3% below the high).

Before this filing the shares had moved −6.9% over the month and −13.1% over three months. Average daily turnover over the last 20 sessions was about ₹7.25 crore.

Promoters held 40.19% at the end of Q2 FY27; 74.09% of promoter shares were pledged. Foreign institutions owned 12.58% and domestic institutions 31.89%.

What history shows

BCEIE has no earlier buyback filing from this company on record since May 2026.

Market-wide, 353 buyback filings with an impact score of 50 or more saw an average next-day move of +0.2%, with 56% rising.

Past reactions describe what happened before; they are not a forecast.

What to watch

• 6 November 2026: Board meeting — Buyback.

In the news

Recent coverage elsewhere (links open the original publisher):

• India's MedPlus Health posts higher Q2 profit as retail revenue rises — Yahoo Finance, 27 Oct 2026
• Medplus Health Services Ltd. Key Financial Ratios – Valuation, Profitability & More — Value Research, 30 Oct 2026
• MedPlus Health Services Ltd. Estimates – NSE:MEDPLUS — TradingView, 23 Oct 2026
• Medplus Health Services: ICICI Prudential Mutual Fund Raises Stake to 9.21% — Whalesbook, 30 Oct 2026
• Medplus Health Services pledge date corrected to July 24, 2026 — scanx.trade, 4 Nov 2026

Source

• Exchange filing (PDF)